Royal Bank of Canada’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460K | Buy |
+114,954
| New | +$460K | ﹤0.01% | 4207 |
|
|
2025
Q1 | – | Sell |
-4,964
| Closed | -$27K | – | 6444 |
|
|
2024
Q4 | $27K | Buy |
+4,964
| New | +$27K | ﹤0.01% | 5486 |
|
|
2024
Q3 | – | Sell |
-7,238
| Closed | -$13K | – | 6455 |
|
|
2024
Q2 | $13K | Buy |
+7,238
| New | +$13K | ﹤0.01% | 5839 |
|
|
2024
Q1 | – | Sell |
-122
| Closed | – | – | 6589 |
|
|
2023
Q4 | $0 | Buy |
+122
| New | – | ﹤0.01% | 6620 |
|
|
2022
Q4 | – | Sell |
-272
| Closed | – | – | 6796 |
|
|
2022
Q3 | $0 | Buy |
+272
| New | – | ﹤0.01% | 6983 |
|
|
2021
Q3 | – | Sell |
-3,000
| Closed | -$8K | – | 7106 |
|
|
2021
Q2 | $8K | Buy |
3,000
+2,000
| +200% | +$5.33K | ﹤0.01% | 6434 |
|
|
2021
Q1 | $3K | Buy |
+1,000
| New | +$3K | ﹤0.01% | 6644 |
|
|
2020
Q4 | – | Sell |
-212
| Closed | -$1K | – | 6516 |
|
|
2020
Q3 | $1K | Buy |
212
+1
| +0.5% | +$5 | ﹤0.01% | 5909 |
|
|
2020
Q2 | $1K | Buy |
211
+1
| +0.5% | +$5 | ﹤0.01% | 5919 |
|
|
2020
Q1 | $0 | Buy |
+210
| New | – | ﹤0.01% | 6162 |
|
|
2018
Q4 | – | Sell |
-253
| Closed | -$2K | – | 5851 |
|
|
2018
Q3 | $2K | Buy |
253
+238
| +1,587% | +$1.88K | ﹤0.01% | 5888 |
|
|
2018
Q2 | $0 | Buy |
15
+12
| +400% | – | ﹤0.01% | 5941 |
|
|
2018
Q1 | $0 | Sell |
3
-81
| -96% | – | ﹤0.01% | 5739 |
|
|
2017
Q4 | $1K | Sell |
84
-636
| -88% | -$7.57K | ﹤0.01% | 5611 |
|
|
2017
Q3 | $11K | Buy |
720
+693
| +2,567% | +$10.6K | ﹤0.01% | 5470 |
|
|
2017
Q2 | $0 | Sell |
27
-90
| -77% | – | ﹤0.01% | 5810 |
|
|
2017
Q1 | $2K | Sell |
117
-41
| -26% | -$701 | ﹤0.01% | 5729 |
|
|
2016
Q4 | $2K | Buy |
+158
| New | +$2K | ﹤0.01% | 5694 |
|